When someone is in pain, they
cannot concentrate on anything other than how to alleviate that pain as quickly
as possible, and many times, Tylenol just isn’t enough. The pain associated
with injury and surgery is unbearable at times, but many people are understandably
cautious about getting prescription narcotics from their doctors because of the
obvious habit-forming, addictive risks associated with these medications.
Nutra-Pharma Corp. (OTCQB: NPHC)
offers a suitable substitute to these potentially dangerous medications with
its Nyloxin product – an all-natural product aimed at treating moderate to
severe chronic pain. Chronic pain is defined as pain that lasts longer than
three months and may be related to certain medical conditions including
diabetes, arthritis, migraines, fibromyalgia, cancer, shingles, sciatica, and
previous trauma or injury.
Nyloxin is available over the
counter and comes in two strengths and three forms, conditional on what is more
convenient and applicable to the person in need – an oral spray, a roll-on and
a topical gel. This makes choosing your remedy much easier, because some people
are wary of the time it takes for pills to work and would rather have a topical
application medication to go right to the source of the pain.
Nyloxin is equivalent to 300 doses
of aspirin and about 1/30 of a dose of morphine. So, you have a supremely
effective method of instant pain relief, literally, in the palm of your hand
that has none of the addictive ramifications of morphine. Substituting an all-natural
form of pain relief (Nyloxin is derived from cobra venom) for habit forming
narcotics or some lower strength over the counter competitors makes more sense
for treating pain in an effective, time oriented manner.
Nyloxin is also becoming available
all over the world, according to a recent letter to shareholders from Nutra
Pharma CEO Rik J. Deitsch. The company announced that it has received
acceptance for Nyloxin from CPAM – the medical authority in China – paving the
way for distribution in the world’s fastest growing consumer market. Also,
Nutra Phama announced its plans to distribute Nyloxin in Canada.
For more information on the
company, visit www.NutraPharma.com
About QualityStocks
QualityStocks is committed to connecting subscribers with
companies that have huge potential to succeed in the short and long-term
future. We offer several ways for investors to find, evaluate, and learn more
about investing in these companies.
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment